MarginsXMarginsX
Home › Markets › Health Care › COO

The Cooper Companies Inc. (COO)

COO trades on Nasdaq in Health Care, Ophthalmic Goods. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$61.88
-1.23% on the day
Market cap
$11.8B
Large cap
Revenue · 2025
$4.1B
+5.1% on 2024
Net income · 2025
$374.9M
9.2% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-10-31, https://www.sec.gov/Archives/edgar/data/711404/000162828025055615/0001628280-25-055615-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-10-31.

Profile

FieldValue
TickerCOO on Nasdaq
SectorHealth Care
IndustryOphthalmic Goods
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000711404
SEC industry codeOphthalmic Goods
Incorporated inDE

Financials · 2025

LineValue
Revenue$4.1B
Net income$374.9M
Operating income$682.9M
Net margin9.2%
Operating margin16.7%
Revenue growth+5.1%
Cash$110.6M
Total assets$12.4B
P/E (computed)31.4×
P/S (computed)2.9×

Warning signs

Cash runway
Cash-flow positive
$154.7M cash at July 31, 2026
Share count, 1 year
-4.4%
2025-08-22 to 2026-09-03 · -4.0% over 3 years
Going-concern doubt
No
10-Q filed September 9, 2026
Insider net buying, 12 months
$3.2M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-09-09
Cash and burn$154.7M cash; operating cash flow $258.3M a quarter.Report 2026-07-31
Shares outstanding190,155,294 (2026-09-03); 198,808,921 a year earlier; 49,524,149 three years earlier. 3y figure adjusted for splits (4-for-1 overall).Cover page 2026-09-03
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorKPMG LLP, San Francisco, California, United StatesPCAOB Form AP 2026-01-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $3.2M, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-07-31
$1.1B$432.8M$341.7M$154.7M$2.5B$4.2B10-Q 2026-09-09
Q2 2026
2026-04-30
$1.1B-$77.9M$182.8M$138.8M$2.5B$4.2B10-Q 2026-06-05
Q1 2026
2026-01-31
$1.0B$130.8M$260.9M$124.9M$2.5B$4.2B10-Q 2026-03-06
Q4 2025
2025-10-31
$1.1B$84.6M$247.9M$110.6M$2.5B$4.1B10-K 2025-12-05
Q3 2025
2025-07-31
$1.1B$98.3M$261.4M$124.9M$2.5B$4.0B10-Q 2026-09-09
Q2 2025
2025-04-30
$1.0B$87.7M$96.2M$116.2M$2.6B$4.0B10-Q 2026-06-05
Q1 2025
2025-01-31
$964.7M$104.3M$190.6M$100.9M$2.5B$3.9B10-Q 2026-03-06
Q4 2024
2024-10-31
$1.0B$117.5M$268.1M$107.6M$2.6B$3.9B10-K 2025-12-05

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest annual report10-K2025-12-05
Latest quarterly / interim10-Q2026-09-09
Latest current report8-K2026-10-27
Latest proxyDEFA14A2026-02-24

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+0.5%
1 month+14.8%
3 months-18.2%
Year to date-23.6%
1 year-12.7%
From 52-week high-25.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Ophthalmic Goods

TickerCompanyPriceDayMarket cap
BLCOBausch + Lomb Corporation Common Shares$20.88-1.00%$7.5B
ALCAlcon Inc.$73.64-0.65%$36.8B
WRBYWarby Parker Inc.$26.23-4.41%$3.3B
EYENational Vision Holdings Inc.$18.74+2.43%$1.5B
STAASTAAR Surgical Company$26.01-1.44%$1.3B
RXSTRxSight Inc.$5.30-0.38%$222.2M
LUCYInnovative Eyewear Inc.$0.7820-3.25%$6.8M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier